Skip to main content

Navigation group

Type at least 3 characters
709 articles

Articles

Original Research

Published on 23 Feb 2022

A Novel Murine Model of a High Dose Brachytherapy-Induced Actinic Proctitis

in Gastrointestinal Cancers: Colorectal Cancer

  • Carlos Heli Bezerra Leite
  • Carlos Diego Holanda Lopes
  • Caio Abner Vitorino Gonçalves Leite
  • Dulce Andrade Terceiro
  • Gabriel Silva Lima
  • JĂ©ssica Andrade Freitas
  • Fernando Queiroz Cunha
  • Paulo Roberto Carvalho Almeida
  • Deysi Viviana Tenazoa Wong
  • Roberto CĂ©sar Pereira Lima-JĂşnior
A Novel Murine Model of a High Dose Brachytherapy-Induced Actinic Proctitis
Frontiers in Oncology
doi 10.3389/fonc.2022.802621
  • 2,611 views
  • 1 citation

Original Research

Published on 18 Feb 2022

Response and Disease Dynamics in Untreated Metastatic Colorectal Cancer With Bevacizumab-Based Sequential vs. Combination Chemotherapy—Analysis of the Phase 3 XELAVIRI Trial

in Gastrointestinal Cancers: Colorectal Cancer

  • Annika Kurreck
  • Volker Heinemann
  • Ludwig Fischer von Weikersthal
  • Thomas Decker
  • Florian Kaiser
  • Jens Uhlig
  • Michael Schenk
  • Jens Freiberg-Richter
  • Bettina Peuser
  • Claudio Denzlinger
Response and Disease Dynamics in Untreated Metastatic Colorectal Cancer With Bevacizumab-Based Sequential vs. Combination Chemotherapy—Analysis of the Phase 3 XELAVIRI Trial
Frontiers in Oncology
doi 10.3389/fonc.2022.751453
  • 2,387 views
  • 1 citation

Original Research

Published on 15 Feb 2022

Effect of Primary Tumor Location on Second- or Later-Line Treatment With Anti-Epidermal Growth Factor Receptor Antibodies in Patients With Metastatic Colorectal Cancer: A Retrospective Multi-Center Study

in Gastrointestinal Cancers: Colorectal Cancer

  • Anita Archwamety
  • Nattaya Teeyapun
  • Teerada Siripoon
  • Naravat Poungvarin
  • Suebpong Tanasanvimon
  • Ekaphop Sirachainan
  • Charuwan Akewanlop
  • Krittiya Korphaisarn
Effect of Primary Tumor Location on Second- or Later-Line Treatment With Anti-Epidermal Growth Factor Receptor Antibodies in Patients With Metastatic Colorectal Cancer: A Retrospective Multi-Center Study
Frontiers in Oncology
doi 10.3389/fonc.2022.813009
  • 2,101 views
  • 3 citations